Gossamer Bio, Inc. (GOSS)
0.5007
-0.02
(-4.04%)
USD |
NASDAQ |
Mar 06, 16:00
0.515
+0.01
(+2.86%)
After-Hours: 20:00
Gossamer Bio SG&A Expense (TTM) : 36.12M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 237.95M |
| Madrigal Pharmaceuticals, Inc. | 813.83M |
| XOMA Royalty Corp. | 32.68M |
| Rezolute, Inc. | 26.27M |
| Axsome Therapeutics, Inc. | 570.60M |